Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Open Access Highly Access Email this article to a friend

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

Glenn Deng, Michael Herrler, David Burgess, Edward Manna, David Krag and Julian F Burke*

Breast Cancer Research 2008, 10:R69 doi:10.1186/bcr2131

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.